PROBIOTICS AND UNDERNOURISHMENT IMPACT ON BRAIN 5-HT SYSTEM AND NEUROTROPHIN BDNF IN RATS: RISK OF DEPRESSION AND ANXIETY? DOI
Simone Evangelista Fonseca,

Cláudia Cristina Alves,

Clarissa Tavares Dias

и другие.

Nutrition, Год журнала: 2024, Номер 132, С. 112680 - 112680

Опубликована: Дек. 31, 2024

Язык: Английский

Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health DOI
Alice Njolke Mafe, Great Iruoghene Edo, Patrick Othuke Akpoghelie

и другие.

Probiotics and Antimicrobial Proteins, Год журнала: 2025, Номер unknown

Опубликована: Янв. 14, 2025

Язык: Английский

Процитировано

10

Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects DOI
Bushra Bashir, Monica Gulati, Sukriti Vishwas

и другие.

Ageing Research Reviews, Год журнала: 2025, Номер unknown, С. 102689 - 102689

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

3

Psychobiotics Ameliorate Depression and Anxiety Status in Surgical Oncology Patients: Results from the ProDeCa Study DOI Open Access
Georgios Tzikos,

E. Chamalidou,

Dimitra Christopoulou

и другие.

Nutrients, Год журнала: 2025, Номер 17(5), С. 857 - 857

Опубликована: Фев. 28, 2025

Background: Psychological disorders are prevalent in patients having undergone gastrointestinal cancer surgery, and their emotional status may further deteriorate during subsequent chemotherapy. Psychobiotics specific probiotics that have the unique characteristics of producing neuroactive substances thought to act on brain-gut axis. The aim present study was evaluate benefits a psychobiotic formula depression anxiety status, as well perceived stress, versus placebo chemotherapy course following surgery for cancer. Patients: enrolled patients, allocated groups, were assessed by means these psychometric tests: Beck's Depression Inventory Hamilton Rating 17-item Scale depression; General Anxiety Disorder-7 anxiety; Perceived Stress Scale-14 Item stress at three time-points: upon allocation [T1], after one month treatment [T2], two months thereafter [T3]. Results: In total, 266 included. One improved [i] 60.4% [48 depressed T1, reduced 16 T3]; [ii] 57.0% [72 26 [iii] [42 14 T3]. placebo-treated experienced deterioration all parameters studied, i.e., increased 62.9%, 39.7%, 142.5%. Conclusions: Based findings, it can be recognized has great potential every patient risk suffering from depression, anxiety, or surgery/chemotherapy

Язык: Английский

Процитировано

1

Exploring Therapeutic Potential of Phytoconstituents as a Gut Microbiota Modulator in the Management of Neurological and Psychological Disorders DOI

Prarit Chandel,

Komal Thapa, Neha Kanojia

и другие.

Neuroscience, Год журнала: 2024, Номер 551, С. 69 - 78

Опубликована: Май 14, 2024

Язык: Английский

Процитировано

4

Postbiotics-peptidoglycan, lipoteichoic acid, exopolysaccharides, surface layer protein and pili proteins—Structure, activity in wounds and their delivery systems DOI
Wang Pu,

Shuxin Wang,

Donghui Wang

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 274, С. 133195 - 133195

Опубликована: Июнь 15, 2024

Язык: Английский

Процитировано

4

Living-loaded hydrogel: Strategies for loading living, interactions between loaded living and hydrogel, and applications DOI
Ran Zhang, Xueyao Liu,

Yanzhe Gou

и другие.

European Polymer Journal, Год журнала: 2024, Номер 213, С. 113130 - 113130

Опубликована: Май 15, 2024

Язык: Английский

Процитировано

3

Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders DOI
Azhagu Madhavan Sivalingam

Clinical Reviews in Allergy & Immunology, Год журнала: 2025, Номер 68(1)

Опубликована: Фев. 11, 2025

Язык: Английский

Процитировано

0

Gut Microbes: Therapeutic Target for Neuropsychiatric Disorders DOI
Keya Mallick, Gopal Khodve,

Ritika Ruwatia

и другие.

Journal of Psychiatric Research, Год журнала: 2025, Номер 184, С. 27 - 38

Опубликована: Фев. 21, 2025

Язык: Английский

Процитировано

0

In Vitro and In Silico Assessment of the Probiotic and Technological Potential of Lacticaseibacillus rhamnosus MW019593 Isolated from Algerian Cow’s Milk DOI
Nassim Madi, Amine M. Boukerb,

Loubna Mekdade

и другие.

Probiotics and Antimicrobial Proteins, Год журнала: 2025, Номер unknown

Опубликована: Март 13, 2025

Язык: Английский

Процитировано

0

Nutraceuticals for Gut–Brain Axis Health: A Novel Approach to Combat Malnutrition and Future Personalised Nutraceutical Interventions DOI Open Access

Litai Liu,

Wen Qi,

Na Zhang

и другие.

Nutrients, Год журнала: 2025, Номер 17(9), С. 1551 - 1551

Опубликована: Апрель 30, 2025

The gut-brain axis (GBA) is a bidirectional communication network between the gastrointestinal tract and brain, modulated by gut microbiota related biomarkers. Malnutrition disrupts GBA homeostasis, exacerbating dysfunction through dysbiosis, impaired neuroactive metabolite production, systemic inflammation. Nutraceuticals, including probiotics, prebiotics, synbiotics, postbiotics, paraprobiotics, offer promising approach to improving homeostasis modulating composition metabolites. This review aims elucidate interplay microbiota-derived biomarkers in malnutrition evaluate potential of nutraceuticals combating malnutrition. Furthermore, it explores future personalised nutraceutical interventions tailored individual genetic microbiome profiles, providing targeted optimise health outcomes. integration into management could transform treatment improve cognitive metabolic health.

Язык: Английский

Процитировано

0